In HGPS patients, cells have shorter telomeres, and treatment with telomerase reverse transcriptase (TERT; catalytic subunit of the telomerase) ameliorates progerin-induced cell proliferation defects (55). This evidence concerns the gene LMNA and Hutchinson-Gilford progeria syndrome.